First year PSA kinetics and nadirs after prostate cancer radiotherapy are predictive of overall survival

被引：0
|
作者：
Cheung, R [1 ]
Tucker, S [1 ]
Kuban, D [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2005年 / 63卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2005.07.345
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1091
引用
收藏
页码：S199 / S200
页数：2
相关论文
共 50 条
  • [1] First-year PSA, kinetics and minima after prostate cancer radiotherapy are predictive of overall survival
    Cheung, Rex
    Tucker, Susan L.
    Kuban, Deborah A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (01): : 20 - 24
  • [2] Predictive Factors for Overall Survival after postoperative Radiotherapy in Patients with Prostate Cancer
    Leufgens, F.
    Berneking, V
    Voegeli, T. -A
    Kirschner-Hermanns, R.
    Eble, M. J.
    Pinkawa, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S84 - S84
  • [3] Pretreatment PSA levels as predictors of overall survival after prostatectomy or radiotherapy for localized prostate cancer
    Kupelian, PA
    Reddy, CA
    Reuther, AM
    Klein, EA
    JOURNAL OF UROLOGY, 2004, 171 (04): : 275 - 275
  • [4] ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
    Hoogland, A. M.
    Jenster, G.
    Van Weerden, W. M.
    Trapman, J.
    Van der Kwast, T.
    Roobol, M. J.
    Schroder, F. H.
    Wildhagen, M. F.
    Van Leenders, G. J. L. H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E425 - U932
  • [5] ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
    Hoogland, A. Marije
    Jenster, Guido
    van Weerden, Wytske M.
    Trapman, Jan
    van der Kwast, Theo
    Roobol, Monique J.
    Schroeder, Fritz H.
    Wildhagen, Mark F.
    van Leenders, Geert J. L. H.
    MODERN PATHOLOGY, 2012, 25 (03) : 471 - 479
  • [6] Impact of biochemical failure on overall survival after radiotherapy for localized prostate carcinoma in the PSA era
    Junker, A
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (11) : 661 - 662
  • [7] PSA kinetics in prostate cancer patients after SBRT radiotherapy using CyberKnife
    Konkol, M.
    Galuba, A.
    Milecki, P.
    Skrobala, A.
    Jodda, A.
    Adamczyk, M.
    Litoborska, J.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S646 - S646
  • [8] PSA kinetics after hypofractionated stereotactic body radiotherapy for localised prostate cancer
    Kim, H.
    Phark, J. H.
    Kim, W. C.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S624 - S624
  • [9] Event-free survival as a composite endpoint (commonly including PSA progression) is not a surrogate for overall survival after radiotherapy for localized prostate cancer
    Nieder, Carsten
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (02) : 164 - 165
  • [10] Survival and PSA relapse data after hypofiractionated radiotherapy for early stage prostate cancer
    Law, A.
    Higgins, G. S.
    Kerr, G. R.
    Mclaren, D. B.
    Howard, G. C. W.
    EJC SUPPLEMENTS, 2007, 5 (04): : 296 - 296
12345